Sofinnova Partners has 7 portfolio companies on record at Recent Funding, with 3 investments in the last 12 months. It is a venture capital firm based in Paris, FR, founded in 1972. It led 4 of the 10 rounds it joined. Its most recent investment on record is Bionyra's $165M Series A round in June 2026, which it led, alongside Jeito Capital, VIVES Funds, Sixty Degree Capital and 4 others. By category, its portfolio leans toward Health and bio (7) and Legal and compliance (1). It has co-invested with Sixty Degree Capital, Jeito Capital and Forbion Capital Partners, most often Sixty Degree Capital (2 rounds).

About Sofinnova Partners

Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Funds raised

Venture funds Sofinnova Partners raised, from the list of new VC funds compiled by Shai Goldman (Brex). Each size links to the article that states it, or to that list where no article was found. All new funds: new VC funds.

What Sofinnova Partners invests in

• Health and bio · 7 · 100%
• Legal and compliance · 1 · 14%
• Data and analytics · 1 · 14%
• Cybersecurity · 1 · 14%

Sofinnova Partners recent investments

Company	Round	Date	Alongside
BBionyra	Series A · $165M · lead	Jun 22, 2026	Jeito Capital (lead), VIVES Funds, Sixty Degree Capital +4
CCellCentric	Series B+ · $220M	May 6, 2026	Venrock Healthcare Capital Partners (lead), RA Capital Management, Pfizer +5
TTenpoint Therapeutics	Series B+ · $235M	Jan 29, 2026	Janus Henderson Investors (lead), Hillhouse Investment (lead), EQT (lead) +6
GGlycoEra	Series B+ · $130M	May 27, 2025	Sixty Degree Capital, Roche Venture Fund, Qatar Investment Authority +6
NNoema Pharma	Series B+ · $112M	Mar 7, 2023	UPMC Enterprises, Polaris, Jeito Capital (lead) +3
HHotSpot Therapeutics	Series B+ · $100M	Nov 29, 2021	Tekla Capital Management, SR One, Revelation Partners +6
GGlycoEra	Series A · $49M · lead	Nov 5, 2021	Roche Venture Fund (lead), LimmaTech Biologics, 5AM Ventures (lead)
NNoema Pharma	Series A · $59M · lead	Dec 1, 2020	Polaris (lead), Invus, Gilde Healthcare +1

How Sofinnova Partners invests

Share is of the 10 rounds on Recent Funding that name Sofinnova Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Sofinnova Partners portfolio companies

• BBionyra$165MSeries A · Jun 2026
• CCellCentric$220MSeries B+ · May 2026
• TTenpoint Therapeutics$235MSeries B+ · Jan 2026
• GGlycoEra$130MSeries B+ · May 2025
• NNoema Pharma$112MSeries B+ · Mar 2023
• HHotSpot Therapeutics$100MSeries B+ · Nov 2021
• FF2Gbacker

Most frequent co-investors

• SSixty Degree Capital2 shared rounds · last Jun 22, 2026
• JJeito Capital2 shared rounds · last Jun 22, 2026
• FForbion Capital Partners2 shared rounds · last May 6, 2026
• RRoche Venture Fund2 shared rounds · last May 27, 2025
• PPolaris2 shared rounds · last Mar 7, 2023
• IInvus2 shared rounds · last Mar 7, 2023
• GGilde Healthcare2 shared rounds · last Mar 7, 2023
• MMRL Ventures Fund2 shared rounds · last Nov 29, 2021
• TTekla Capital Management2 shared rounds · last Nov 29, 2021
• SSR One2 shared rounds · last Nov 29, 2021
• AAtlas Venture2 shared rounds · last May 21, 2020
• SSanofi Ventures1 shared round · last Jun 22, 2026

Similar investors

• KKorea Investment Partners7 companies · 4 deals in 12 mo
• MMarch Capital7 companies · 3 deals in 12 mo
• NNight Capital7 companies · 3 deals in 12 mo
• EElaia7 companies · 2 deals in 12 mo
• EEQT Life Sciences7 companies · 2 deals in 12 mo
• MMoore Strategic Ventures7 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Sofinnova Partners, which is a subset of its real portfolio. API: /api/v1/investors/sofinnova-partners (get a free API key). More: the most active VC firms and new venture capital funds.